Antibodies is an international, peer-reviewed, open access journal on immunoglobulins, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 22.2 days after submission; acceptance to publication is undertaken in 5.8 days (median values for papers published in this journal in the first half of 2022).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Antibodies, COVID, Pathogens, Vaccines, Viruses
Host Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development Topic Editors: Fabrizio Angius, Meng Ling Moi
Deadline: 31 August 2023
Special Issue in Antibodies
Monoclonal Antibody-Directed Therapy Series II Guest Editors: Amita Datta-Mannan, Brooke Rock
Deadline: 20 December 2022
Special Issue in Antibodies
Novel Approaches in Discovery and Design of Antibody-Based Therapeutics Guest Editor: Alastair Lawson
Deadline: 20 January 2023
Special Issue in Antibodies
Higher Order Structure Characterization of Therapeutic Antibodies-Second Volume Guest Editor: Aaron T. Wecksler
Deadline: 10 February 2023
Special Issue in Antibodies
Novel Strategies and Technologies for the Development of Tumor-Specific Antibodies Guest Editor: Alexander J. Bankovich
Deadline: 15 March 2023
Topical Collection in Antibodies
Computational Antibody and Antigen Design Collection Editor: Buyong Ma
Back to TopTop